Millennium Management’s Vor Biopharma VOR Stock Holding History

Millennium Management’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.61M	Buy	258,587 +34,053	+15%	+$480K	﹤0.01%	3039
2025 Q4	$2.94M	Buy	224,534 +199,770	+807%	+$3.72M	﹤0.01%	3582
2025 Q3	$1.21M	Buy	+24,764	New	+$996K	﹤0.01%	4482
2025 Q2	–	Sell	-9,342	Closed	-$82.6K	–	6363
2025 Q1	$134K	Sell	9,342 -3,750	-29%	-$90K	﹤0.01%	5387
2024 Q4	$291K	Sell	13,092 -2,099	-14%	-$34.8K	﹤0.01%	5089
2024 Q3	$213K	Sell	15,191 -4,291	-22%	-$78.2K	﹤0.01%	5415
2024 Q2	$390K	Buy	19,482 +11,562	+146%	+$374K	﹤0.01%	4751
2024 Q1	$375K	Buy	+7,920	New	+$348K	﹤0.01%	4996
2023 Q3	–	Sell	-3,135	Closed	-$194K	–	6612
2023 Q2	$194K	Sell	3,135 -17,208	-85%	-$1.57M	﹤0.01%	5130
2023 Q1	$2.19M	Sell	20,343 -4,561	-18%	-$506K	﹤0.01%	3358
2022 Q4	$3.31M	Buy	24,904 +7,958	+47%	+$787K	﹤0.01%	3131
2022 Q3	$1.35M	Buy	16,946 +2,499	+17%	+$246K	﹤0.01%	4090
2022 Q2	$1.44M	Buy	14,447 +13,616	+1,639%	+$1.39M	﹤0.01%	4034
2022 Q1	$100K	Buy	+831	New	+$141K	﹤0.01%	6152
2021 Q3	–	Sell	-917	Closed	-$342K	–	7292
2021 Q2	$342K	Buy	+917	New	+$452K	﹤0.01%	5637

Other funds holding VOR

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's VOR Position: Q1 2026 in Review

Millennium Management increased its Vor Biopharma (VOR) stake by 15% in Q1 2026, buying an estimated $480K and bringing the position to 258,587 shares worth $4.61M. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

Millennium Management first reported a position in VOR in Q2 2021 and has held it in 15 quarters since. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

Millennium Management held 258,587 shares of Vor Biopharma worth $4.61M as of Q1 2026.
Millennium Management bought 34,053 Vor Biopharma shares in Q1 2026, an estimated $480K.
Vor Biopharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3039 holding.
Millennium Management first reported a position in Vor Biopharma in Q2 2021 and has held it in 15 quarters since.
80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.